WHO ICTRP trial

Sentinel lymph node excision in the head and neck area for cutaneous…

DRKS00004622 · German Clinical Trials Register · Not Recruiting

Key facts

Trial ID DRKS00004622
Public title Sentinel lymph node excision in the head and neck area for cutaneous malignancies: clinical evaluation of a hybrid tracer (technetium and indocyanine) versus technetium labeling
Scientific title Sentinel lymph node excision in the head and neck area for cutaneous malignancies: clinical evaluation of a hybrid tracer (technetium and indocyanine) versus technetium labeling - SLNE-Hybrid
Primary sponsor Universitätsklinikum Essen, Klinik für Dermatologie und Venerologie
Registry German Clinical Trials Register
Recruitment status Not Recruiting
Study type interventional
Countries Germany
Conditions C43 C44;Malignant melanoma of skin;Other malignant neoplasms of skin
Interventions Group 1: Lymphoscintigraphy with 99m-technetium and intraoperative fluorescence detection of indocyanin green Group 2: Lymphoscintigraphy with 99m-technetium
Registration date Jan 22, 2013
Target size 40
Registry page drks.de

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations